Diphlorethohydroxycarmalol Suppresses Ultraviolet B-Induced Matrix Metalloproteinases via Inhibition of JNK and ERK Signaling in Human Keratinocytes |
Piao, Mei Jing
(School of Medicine, College of Natural Sciences, Jeju National University)
Kumara, Madduma Hewage Susara Ruwan (School of Medicine, College of Natural Sciences, Jeju National University) Kim, Ki Cheon (School of Medicine, College of Natural Sciences, Jeju National University) Kang, Kyoung Ah (School of Medicine, College of Natural Sciences, Jeju National University) Kang, Hee Kyoung (School of Medicine, College of Natural Sciences, Jeju National University) Lee, Nam Ho (Department of Chemistry, College of Natural Sciences, Jeju National University) Hyun, Jin Won (School of Medicine, College of Natural Sciences, Jeju National University) |
1 |
Brenneisen, P., Briviba, K., Wlaschek, M., Wenk, J. and Scharffetter-Kochanek, K. (1997) Hydrogen peroxide ( |
2 | Brenneisen, P., Sies, H. and Scharffetter-Kochanek, K. (2002) Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. N. Y. Acad. Sci. 973, 31-43. DOI |
3 | Brinckerhoff, C. E. and Matrisian, L. M. (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3, 207-214. DOI |
4 | Cano, E., Hazzalin, C. A. and Mahadevan, L. C. (1994) Anisomycinactivated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and-2 are implicated in the induction of cfos and c-jun. Mol. Cell Biol. 14, 7352-7362. DOI |
5 | Chen, K., Chen, J., Li, D., Zhang, X. and Mehta, J. L. (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44, 655-661. DOI |
6 | Crawford, H. C. and Matrisian, L. M. (1996) Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 20-37. DOI |
7 | Dasgupta, J., Kar, S., Liu, R., Joseph, J., Kalyanaraman, B., Remington, S. J., Chen, C. and Melendez, J. A. (2010) Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell Physiol. 225, 52-62. DOI |
8 | Davidson, B., Givant-Horwitz, V., Lazarovici, P., Risberg, B., Nesland, J., Trope, C. G., Schaefer, E. and Reich, R. (2003) Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clin. Exp. Metastasis 20, 621-631. DOI |
9 | Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R. and Futreal, P. A. (2002) Mutations of the BRAF gene in human cancer. Nature 417, 949-954. DOI |
10 | Eliopoulos, A. G. and Young, L. S. (1998) Activation of the cJun Nterminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16, 1731-1742. DOI |
11 | Fagot, D., Asselineau, D. and Bernerd, F. (2002) Direct role of human dermal fibroblasts and indirect participation of epidermal keratinocytes in MMP-1 production after UV-B irradiation. Arch. Dermatol. Res. 293, 576-583. DOI |
12 | Farrell, P. J, Rowe, D. T, Rooney, C. M. and Kouzarides, T. (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8, 127-132. |
13 | Glover, J. N. and Harrison, S. C. (1995) Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261. DOI |
14 | Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A. and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632. DOI |
15 | Fisher, G. J., Kang, S., Varani, J., Bata-Csorgo, Z., Wan, Y., Datta, S. and Voorhees, J. J. (2002) Mechanisms of photoaging and chronological skin aging. Arch. Dermatol. 138, 1462-1470. |
16 | Frost, J. A, Geppert, T. D, Cobb, M. H. and Feramisco, J. R. (1994) A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. U.S.A. 91, 3844-3848. DOI |
17 | Goffin, L., Seguin-Estevez, Q., Alvarez, M., Reith, W. and Chizzolini, C. (2010) Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts. Arthritis Res. Ther. 12, R73. DOI |
18 |
Heo, S. J. and Jeon, Y. J. (2009) Evaluation of diphlorethohydroxycarmalol isolated from Ishige okamurae for radical scavenging activity and its protective effect against |
19 | Heo, S. J., Hwang, J. Y., Choi, J. I., Han, J. S., Kim, H. J. and Jeon, Y. J. (2009) Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent [alpha]-glucosidase and [alpha]-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 615, 252-256. DOI |
20 | Heo, S. J., Ko, S. C., Kang, S. M., Cha, S. H., Lee, S. H., Kang, D. H., Jung, W. K., Affan, A., Oh, C. and Jeon, Y. J. (2010) Inhibitory effect of diphlorethohydroxycarmalol on melanogenesis and its protective effect against UV-B radiation-induced cell damage. Food Chem. Toxicol. 48, 1355-1361. DOI |
21 | Jacob, M. P. (2003) Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed. Pharmacother. 57, 195-202. DOI |
22 | Jo, W. S., Yang, K. M., Park, H. S., Kim, G. Y., Nam, B. H., Jeong, M. H. and Choi, Y. J. (2012) Effect of microalgal extracts of tetraselmis suecica against UVB-induced photoaging in human skin fibroblasts. Toxicol. Res. 28, 241-248. DOI |
23 | Kahari, V. M. and Saarialho-Kere, U. (1997) Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213. DOI |
24 | Kang, K. A., Zhang, R., Piao, M. J., Ko, D. O., Wang, Z. H., Kim, B. J., Park, J. W., Kim, H. S., Kim, D. H. and Hyun, J. W. (2008a) Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg. Med. Chem. 16, 1133-1141. DOI |
25 | Kang, K. A., Zhang, R., Piao, M. J., Ko, D. O., Wang, Z. H., Lee, K., Kim, B. J., Shin, T., Park, J. W., Lee, N. H., Yoo, B. S. and Hyun, J. W. (2008b) Inhibitory effects of triphlorethol-A on MMP-1 induced by oxidative stress in human keratinocytes via ERK and AP-1 inhibition. J. Toxicol. Environ. Health A. 71, 992-999. DOI |
26 | Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16, 6478-6485. DOI |
27 | Mook, O. R., Frederiks, W. M. and Van Noorden, C. J. (2004). The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 1705, 69-89. |
28 | Kim, C., Ryu, H. C. and Kim, J. H. (2010) Low-dose UVB irradiation stimulates matrix metalloproteinase-1 expression via a BLT2-linked pathway in HaCaT cells. Exp. Mol. Med. 42, 833-841. DOI |
29 | Kim, H. H., Shin, C. M., Park, C. H., Kim, K. H., Cho, K. H., Eun, H. C. and Chung, J. H. (2005) Eicosapentaenoic acid inhibits UVinduced MMP-1 expression in human dermal fibroblasts. J. Lipid Res. 46, 1712-1720. DOI |
30 | Lin, C. W., Georgescu, H. I. and Evans, C. H. (1993) The role of AP-1 in matrix metalloproteinase gene expression. Agents Actions 39, 215-218. DOI |
31 | Murphy, L. O, Smith, S., Chen, R. H, Fingar, D. C. and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564. DOI |
32 | Purcell, W. T., Rudek, M. A. and Hidalgo, M. (2002) Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol. Oncol. Clin. North Am. 16, 1189-1227. DOI |
33 | Reel, B., Oktay, G., Ozkal, S., Islekel, H., Ozer, E., Ozsarlak-Sozer, G., Cavdar, Z., Akhisaroglu, S. T. and Kerry Z. (2009) MMP-2 and MMP-9 alteration in response to collaring in rabbits: the effects of endothelin receptor antagonism J. Cardiovasc. Pharmacol. Ther. 14, 292-301. DOI |
34 | Ren, S. W., Li, J., Wang, W. and Guan, H. S. (2010) Protective effects of kappa-ca3000+CP against ultraviolet-induced damage in HaCaT and MEF cells. J. Photochem. Photobiol. B. 101, 22-30. DOI |
35 | Wenk, J., Brenneisen, P., Wlaschek, M., Poswig, A., Briviba, K., Oberley, T. D. and Scharffetter-Kochanek, K. (1999) Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274, 25869-25876. DOI |
36 | Sunami, E., Tsuno, N., Osada, T., Saito, S., Kitayama, J., Tomozawa, S., Tsuruo, T., Shibata, Y., Muto, T. and Nagawa, H. (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5, 108-114. DOI |
37 | Tsareva, S. A., Moriggl, R., Corvinus, F. M., Wiederanders, B., Schutz, A., Kovacic, B. and Friedrich, K. (2007) Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9, 279-291. DOI |
38 | Wenham, R., Calingaert, B., Ali, S., McClean, K., Whitaker, R., Bentley, R., Lancaster, J., Schildkraut, J., Marks, J. and Berchuck, A. (2003) Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J. Soc. Gynecol. Investig. 10, 381-387. DOI |
39 | Westermarck, J. and Kahari, V. M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792. DOI |
40 | Wu, H. M., Wen, H. C. and Lin, W. W. (2002) Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signalregulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation. Am. J. Respir. Cell Mol. Biol. 27, 234-243. DOI |
41 | Yaar, M. and Gilchrest, B. A. (2007) Photoageing: mechanism, prevention and therapy. Br. J. Dermatol. 157, 874-887. DOI |
42 | Bogoyevitch, M. A., Ngoei, K. R., Zhao, T. T., Yeap, Y. Y. and Ng, D. C. (2010) c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochim. Biophys. Acta 1804, 463-475. DOI |
43 | Benbow, U. and Brinckerhoff, C.E. (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15, 519-526. DOI |
44 | Berne, B., Vahlquist, A., Fischer, T., Danielson, B. G. and Berne, C. (1984) UV treatment of uraemic pruritus reduces the vitamin A content of the skin. Eur. J. Clin. Invest. 14, 203-206. DOI |
![]() |